
Paul D. Kim
Examiner (ID: 16017, Phone: (571)272-4565 , Office: P/3729 )
| Most Active Art Unit | 3729 |
| Art Unit(s) | 3729 |
| Total Applications | 2890 |
| Issued Applications | 2435 |
| Pending Applications | 152 |
| Abandoned Applications | 345 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18420111
[patent_doc_number] => 20230174572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/747952
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747952
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/747952 | SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS | May 17, 2022 | Pending |
Array
(
[id] => 17836313
[patent_doc_number] => 20220273618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => PROTEIN HYDROLYSATES
[patent_app_type] => utility
[patent_app_number] => 17/745104
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745104
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745104 | PROTEIN HYDROLYSATES | May 15, 2022 | Abandoned |
Array
(
[id] => 18065514
[patent_doc_number] => 20220396601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => HEME SEQUESTING PEPTIDES AND USES THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/743835
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29327
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743835 | Heme sequesting peptides and uses therefor | May 12, 2022 | Issued |
Array
(
[id] => 17850563
[patent_doc_number] => 20220280604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => Composition for boosting the immune system
[patent_app_type] => utility
[patent_app_number] => 17/714166
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714166
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714166 | Composition for boosting the immune system | Apr 5, 2022 | Pending |
Array
(
[id] => 17761493
[patent_doc_number] => 20220235105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => METHODS AND COMPOSITIONS FOR VISUALIZING SUMO
[patent_app_type] => utility
[patent_app_number] => 17/712706
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712706
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/712706 | METHODS AND COMPOSITIONS FOR VISUALIZING SUMO | Apr 3, 2022 | Abandoned |
Array
(
[id] => 17944424
[patent_doc_number] => 20220331441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => Tumor-Targeting Polypeptide Nanoparticle Delivery System for Nucleic Acid Therapeutics
[patent_app_type] => utility
[patent_app_number] => 17/713037
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713037
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/713037 | Tumor-Targeting Polypeptide Nanoparticle Delivery System for Nucleic Acid Therapeutics | Apr 3, 2022 | Pending |
Array
(
[id] => 17720453
[patent_doc_number] => 20220213173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => MODIFIED COLLAGEN
[patent_app_type] => utility
[patent_app_number] => 17/700120
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700120
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700120 | MODIFIED COLLAGEN | Mar 20, 2022 | Abandoned |
Array
(
[id] => 17720453
[patent_doc_number] => 20220213173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => MODIFIED COLLAGEN
[patent_app_type] => utility
[patent_app_number] => 17/700120
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700120
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700120 | MODIFIED COLLAGEN | Mar 20, 2022 | Abandoned |
Array
(
[id] => 17672674
[patent_doc_number] => 20220185841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTIVE GROUP, AND HYDRAZINE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/654060
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17654060
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/654060 | METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTIVE GROUP, AND HYDRAZINE DERIVATIVE | Mar 7, 2022 | Abandoned |
Array
(
[id] => 18243756
[patent_doc_number] => 20230076067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => MITOCHONDRIAL-TARGETED ANTIOXIDANTS PROTECT AGAINST MECHANICAL VENTILATION-INDUCED DIAPHRAGM DYSFUNCTION AND SKELETAL MUSCLE ATROPHY
[patent_app_type] => utility
[patent_app_number] => 17/680778
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680778
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/680778 | MITOCHONDRIAL-TARGETED ANTIOXIDANTS PROTECT AGAINST MECHANICAL VENTILATION-INDUCED DIAPHRAGM DYSFUNCTION AND SKELETAL MUSCLE ATROPHY | Feb 24, 2022 | Abandoned |
Array
(
[id] => 18685175
[patent_doc_number] => 11780893
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Kv1.3 blockers
[patent_app_type] => utility
[patent_app_number] => 17/679925
[patent_app_country] => US
[patent_app_date] => 2022-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18182
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 329
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679925
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/679925 | Kv1.3 blockers | Feb 23, 2022 | Issued |
Array
(
[id] => 17761491
[patent_doc_number] => 20220235103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => NOVEL ANKYRIN REPEAT BINDING PROTEINS AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 17/650792
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650792
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650792 | NOVEL ANKYRIN REPEAT BINDING PROTEINS AND THEIR USES | Feb 10, 2022 | Abandoned |
Array
(
[id] => 18970433
[patent_doc_number] => 20240050525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => METHODS OF TREATING, DIAGNOSING AND PREDICTING PROGNOSIS OF SEPSIS
[patent_app_type] => utility
[patent_app_number] => 18/259092
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259092
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259092 | METHODS OF TREATING, DIAGNOSING AND PREDICTING PROGNOSIS OF SEPSIS | Jan 30, 2022 | Pending |
Array
(
[id] => 19121046
[patent_doc_number] => 11965016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Crystal structures comprising elastin-like peptides
[patent_app_type] => utility
[patent_app_number] => 17/588579
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 39
[patent_no_of_words] => 26751
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588579
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588579 | Crystal structures comprising elastin-like peptides | Jan 30, 2022 | Issued |
Array
(
[id] => 18970433
[patent_doc_number] => 20240050525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => METHODS OF TREATING, DIAGNOSING AND PREDICTING PROGNOSIS OF SEPSIS
[patent_app_type] => utility
[patent_app_number] => 18/259092
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259092
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259092 | METHODS OF TREATING, DIAGNOSING AND PREDICTING PROGNOSIS OF SEPSIS | Jan 30, 2022 | Pending |
Array
(
[id] => 17760092
[patent_doc_number] => 20220233704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => MUTANTS AND DRUG CONJUGATES OF R-SPONDINS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/586258
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17586258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/586258 | MUTANTS AND DRUG CONJUGATES OF R-SPONDINS AND USE THEREOF | Jan 26, 2022 | Pending |
Array
(
[id] => 17595331
[patent_doc_number] => 20220144904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => Composition for and Method of Improving Tissue Performance
[patent_app_type] => utility
[patent_app_number] => 17/583549
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583549
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/583549 | Composition for and Method of Improving Tissue Performance | Jan 24, 2022 | Pending |
Array
(
[id] => 17595331
[patent_doc_number] => 20220144904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => Composition for and Method of Improving Tissue Performance
[patent_app_type] => utility
[patent_app_number] => 17/583549
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583549
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/583549 | Composition for and Method of Improving Tissue Performance | Jan 24, 2022 | Pending |
Array
(
[id] => 18075118
[patent_doc_number] => 20220400730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => COMPOSITIONS, METHODS, KITS AND SYSTEMS FOR CANCER TREATMENT AND METABOLIC INTERVENTION THERAPY AND OTHER USES
[patent_app_type] => utility
[patent_app_number] => 17/579408
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579408
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579408 | COMPOSITIONS, METHODS, KITS AND SYSTEMS FOR CANCER TREATMENT AND METABOLIC INTERVENTION THERAPY AND OTHER USES | Jan 18, 2022 | Abandoned |
Array
(
[id] => 19172469
[patent_doc_number] => 20240158443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => Compositions And Methods of Synthesizing Shape Shifting Cyclic Peptides (Sscp) And Their Use in The Identification of Novel Therapeutic Compounds
[patent_app_type] => utility
[patent_app_number] => 18/272674
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272674
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/272674 | Compositions and methods of synthesizing shape shifting cyclic peptides (Sscp) and their use in the identification of novel therapeutic compounds | Jan 18, 2022 | Issued |